Role of α 1- and β 3-adrenoceptors in the modulation by SR59230A of the effects of MDMA on body temperature in the mouse

British Journal of Pharmacology

Volumn 158, Issue 1, 2009, Pages 259-266

  Bexis, Sotiria ^a   Docherty, James R ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

1 drenoceptor; 3 adrenoceptor; Hyperthermia; Hypothermia; MDMA

Indexed keywords

1 (2 ETHYLPHENOXY) 3 (1,2,3,4 TETRAHYDRO 1 NAPHTHYLAMINO) 2 PROPANOL OXALATE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALPHA 1 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; PRAZOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG RECEPTOR BINDING; HYPERTHERMIA; HYPOTHERMIA; LIGAND BINDING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BODY TEMPERATURE; FEVER; MALE; MICE; MICE, INBRED C57BL; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PROPANOLAMINES; PROTEIN BINDING; RATS; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA-3;

EID: 69249211020     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00186.x     Document Type: Article

References (27)

1. Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edn. Br J Pharmacol 153 (Suppl. 2 S1 S209.
2. Al Zubair K, Bexis S, Docherty JR (2008). Relaxations to beta-adrenoceptor subtype selective agonists in wild-type and NOS-3-KO mouse mesenteric arteries. Eur J Pharmacol 587 : 216 223.
3. Battaglia G, Brooks BP, Kulsakdinun C, De Souza EB (1988). Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites. Eur J Pharmacol 149 : 159 163.
4. 2A-adrenoceptors in the effects of MDMA on body temperature in the mouse. Br J Pharmacol 146 : 1 6.
5. Bexis S, Docherty JR (2006). Effects of MDMA, MDA and MDEA on blood pressure, heart rate, locomotor activity and body temperature in the rat involve α-adrenoceptors. Br J Pharmacol 147 : 926 934.
6. 1-adrenoceptor subtypes in the effects of methylenedioxy methamphetamine (MDMA) on body temperature in the mouse. Br J Pharmacol 153 : 591 597.
7. 3-adrenoceptors antagonist SR59230A in the mouse. Proceedings of BPS (in press).
8. 3- or atypical β beta-adrenoceptors in rat aorta. Br J Pharmacol 142 : 781 787.
9. Cheung YD, Barnett DB, Nahorski SR (1982 3H]Rauwolscine and [3H]yohimbine binding to rat cerebral and human platelet membranes: possible heterogeneity of alpha 2-adrenoceptors. Eur J Pharmacol 84 : 79 85.
10. Connaughton S, Docherty JR (1990). Functional evidence for heterogeneity of peripheral prejunctional alpha 2-adrenoceptors. Br J Pharmacol 101 : 285 290.
11. Fantegrossi WE, Godlewski T, Karabenick RL, Stephens JM, Ullrich T, Rice KC et al. (2003). Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ('ecstasy') and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice. Psychopharmacology 166 : 202 211.
12. Green AR, O'Shea E, Saadat KS, Elliott JM, Colado MI (2005). Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures. Br J Pharmacol 146 : 306 312.
13. 2-adrenoceptor mediated actions of MDMA in rat atrium and vas deferens. Br. J. Pharmacol 128 : 975 980.
14. Leblais V, Pourageaud F, Ivorra MD, Guibert C, Marthan R, Muller B (2004). Role of alpha-adrenergic receptors in the effect of the beta-adrenergic receptor ligands, CGP 12177, bupranolol, and SR 59230A, on the contraction of rat intrapulmonary artery. J Pharmacol Exp Ther 309 : 137 145.
15. Malberg JE, Seiden LS (1998). Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci 18 : 5086 5094.
16. Manara L, Badone D, Baroni M, Boccardi G, Cecchi R, Croci T et al. (1996). Functional identification of rat atypical beta-adrenoceptors by the first beta 3-selective antagonists, aryloxypropanolaminotetralins. Br J Pharmacol 117 : 435 442.
17. McDaid J, Docherty JR (2001). Vascular actions of MDMA involve α1 and α2-adrenoceptors in the anaesthetized rat. Br J Pharmacol 133 : 429 437.
18. Michel AD, Loury DN, Whiting RL (1989). Identification of a single alpha 1-adrenoceptor corresponding to the alpha 1A-subtype in rat submaxillary gland. Br J Pharmacol 98 : 883 889.
19. Miller DB, O'Callaghan JP (1995). The role of temperature, stress, and other factors in the neurotoxicity of the substituted amphetamines 3,4-methylenedioxymethamphetamine and fenfluramine. Mol Neurobiol 11 : 177 192.
20. Neylon CB, Summers RJ (1985 3H]-rauwolscine binding to alpha 2-adrenoceptors in the mammalian kidney: apparent receptor heterogeneity between species. Br J Pharmacol 85 : 349 359.
21. Nisoli E, Tonello C, Landi M, Carruba MO (1996). Functional studies of the first selective beta 3-adrenergic receptor antagonist SR 59230A in rat brown adipocytes. Mol Pharmacol 49 : 7 14.
22. Qvigstad E, Sjaastad I, Bøkenes J, Schiander I, Solberg L, Sejersted OM et al. (2005). Carvedilol blockade of alpha1- and beta-adrenoceptor induced inotropic responses in rats with congestive heart failure. Eur J Pharmacol 516 : 51 59.
23. Sprague JE, Banks ML, Cook VJ, Mills EM (2003). Hypothalamic-pituitary- thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphatamine (Ecstasy). J Pharmacol Exp Ther 305 : 159 166.
24. 1- plus β3-adrenoceptor antagonists. Br J Pharmacol 142 : 667 670.
25. Sprague JE, Moza P, Caden D, Rusyniak DE, Homes C, Goldstein DS et al. (2005). Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3,4-methylenedioxymethamphatamine (MDMA, Ecstasy) in an animal model. Crit Care Med 33 : 1311 1316.
26. Vrydag W, Michel MC (2007). Tools to study beta3-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol 374 : 385 398.
27. White SR, Obradovic T, Imel KM, Wheaton MJ (1996). The effects of methylenedioxymethamphetamine (MDMA, 'ecstasy') on monoaminergic neurotransmission in the central nervous system. Prog Neurobiol 49 : 455 479.